Mirae Asset Global Investments Co. Ltd. Has $314,000 Position in AdaptHealth Corp. (NASDAQ:AHCO)

Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 30.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,065 shares of the company’s stock after buying an additional 10,162 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in AdaptHealth were worth $314,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of AHCO. SG Americas Securities LLC acquired a new stake in AdaptHealth during the third quarter worth $350,000. Oak Thistle LLC bought a new position in shares of AdaptHealth during the third quarter valued at $94,000. Simplicity Solutions LLC bought a new position in shares of AdaptHealth during the third quarter valued at $315,000. Commonwealth Equity Services LLC lifted its holdings in shares of AdaptHealth by 28.6% during the third quarter. Commonwealth Equity Services LLC now owns 41,482 shares of the company’s stock valued at $377,000 after acquiring an additional 9,214 shares during the period. Finally, Raymond James & Associates bought a new position in shares of AdaptHealth during the third quarter valued at $101,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

Analysts Set New Price Targets

AHCO has been the subject of a number of analyst reports. Royal Bank of Canada reissued an “outperform” rating and set a $13.00 price objective on shares of AdaptHealth in a report on Monday, March 4th. Truist Financial lifted their price objective on AdaptHealth from $11.00 to $13.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. UBS Group lifted their price objective on AdaptHealth from $9.00 to $13.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. Finally, Jefferies Financial Group cut AdaptHealth from a “buy” rating to a “hold” rating and cut their price objective for the company from $14.50 to $8.00 in a report on Monday, January 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $12.10.

Insider Buying and Selling

In related news, major shareholder James E. Flynn sold 52,487 shares of AdaptHealth stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $10.93, for a total value of $573,682.91. Following the completion of the sale, the insider now directly owns 11,826,376 shares in the company, valued at $129,262,289.68. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, major shareholder James E. Flynn sold 182,607 shares of AdaptHealth stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $11.02, for a total value of $2,012,329.14. Following the completion of the sale, the insider now directly owns 11,643,769 shares in the company, valued at $128,314,334.38. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder James E. Flynn sold 52,487 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $10.93, for a total value of $573,682.91. Following the transaction, the insider now owns 11,826,376 shares of the company’s stock, valued at $129,262,289.68. The disclosure for this sale can be found here. Corporate insiders own 13.60% of the company’s stock.

AdaptHealth Stock Performance

AdaptHealth stock opened at $9.96 on Friday. The stock has a 50-day simple moving average of $10.05 and a 200 day simple moving average of $8.44. The company has a quick ratio of 1.00, a current ratio of 1.21 and a debt-to-equity ratio of 1.44. AdaptHealth Corp. has a 12-month low of $6.37 and a 12-month high of $15.37. The stock has a market capitalization of $1.32 billion, a price-to-earnings ratio of -1.88, a P/E/G ratio of 0.63 and a beta of 1.02.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.44. The firm had revenue of $858.23 million during the quarter, compared to analyst estimates of $825.94 million. AdaptHealth had a positive return on equity of 8.84% and a negative net margin of 21.21%. On average, research analysts anticipate that AdaptHealth Corp. will post 0.88 earnings per share for the current fiscal year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.